Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

8.31 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12001 Q32001 Q22001 Q1
Operating Activities:
Net Income -217.181-165.911-211.694-302.891-173.315-204.969-174.154-669.055-670.57-592.593-1,604.995-102.405-54.464-74.778-46.399-26.055-28.658-24.97200-592.593
Depreciation & Amortization 17.3312.86912.83720.49118.22118.95815.8219.5069.6089.4888.0038.2797.1655.6294.0043.5273.1793.1549.2249.3269.488
Deferred Income Tax 00-0.801146.8360.0670-14.609000-57.88270.5011.59116.002-30.006000014.013
Stock Based Compensation 37.14640.78242.83752.57361.48872.986108.169563.136606.515652.8211,591.2560.12714.5190.1180.1180.1180.1170.123563.385607.27652.821
Change In Working Capital 5.880.31251.333-1.825-11.8821.488-18.74844.863-52.972-10.149-92.34225.2452.4873.073-13.296-5.4432.1640.42100-14.013
Accounts Receivables 5.668-6.7728.95.77115.923-0.52634.50359.119-3.67-34.928-85.424-22.1913.062-9.541-7.444-10.1233.847-0.50800-34.928
Change In Inventory 00-10.7788.2290.6941.8552.6622.2420.595-5.3350.112-0.7580.701-0.681-1.917-0.8190000-5.335
Change In Accounts Payables -0.00710.8713.639-7.815-6.6869.679-14.737-6.757-15.626.250.5244.55-7.8370.5164.3190000026.25
Other Working Capital 0.219-3.78929.572-8.01-21.813-9.52-41.176-9.741-34.2973.864-7.55443.6446.56112.779-8.2545.499-1.6830.9290014.013
Other Non Cash Items 138.5885.10856.93411.26531.88820.952-21.1823.2488.122-79.465-9.581-6.982-6.2091.825-0.7662.583-4.011-2.738-572.609-616.596-89.614
Operating Cash Flow -84.39-89.259-48.554-73.551-73.533-90.585-104.701-28.302-99.297-19.898-165.541-5.235-34.911-48.131-59.339-25.27-27.209-24.012572.609616.596-19.898
Investing Activities:
Investments In Property Plant And Equipment -27.032-6.71-3.446-4.381-13.533-19.441-25.645-13.473-9.573-3.58-5.114-5.438-24.034-21.935-19.413-28.667-6.462-3.27900-3.58
Acquisitions Net 0.191-5.4-41.5520.0742.3090.61783.024-29.0461.44-28.7729.342-20.1720-1.210000000
Purchases Of Investments 00000010-10-6.5-3.691-5-50-1,7250000000
Sales Maturities Of Investments 000000006.504.696-0.1240.12400000000
Other Investing Activites 00-1.6760.9262.309-0.59-37.6396.033-6.530.0580.3040.1020.1030.099-9.4170.1060.011000-32.405
Investing Cash Flow -26.841-12.11-46.674-3.381-11.224-19.41429.74-46.486-14.663-35.9854.228-30.508-23.931-23.046-28.83-28.561-6.451-3.27900-35.985
Financing Activities:
Debt Repayment -0.2-0.294-0.318-0.329-0.326-0.322-0.155-0.362-0.434-0.286-0.359-0.316-0.163-0.285-0.193-0.16-0.19-0.20500-0.286
Common Stock Issued 0.0140.07-0.48700.566-0.5660.24-0.0880.0010.0750.167-242.76901,753.7190000000.075
Common Stock Repurchased 00-0.0230-0.0120-0.9810-0.075-0.981-24.998-24.998000000000
Dividends Paid 00-0.5540000000-24.9570000000000
Other Financing Activities -0.04-0.6210.1730.014-1.621-0.57897.848-0.088-0.52-0.90639.1041,548.06-1.96-0.1480.00722.42772.012-3.3800-0.981
Financing Cash Flow -0.226-0.845-0.632-0.315-1.381-0.88897.933-0.45-0.954-1.192-11.0431,547.744-2.123-0.433-0.18622.26771.822-3.58500-1.192
Other Information:
Effect Of Forex Changes On Cash -0.016-0.1570.102-0.195-0.469-0.0261.099-0.087-0.096-0.008-0.011-0.008000000000.042
Net Change In Cash -111.048-105.094-103.729-77.442-86.607-110.91324.071-75.325-115.01-57.083-172.3671,511.993-60.965-71.61-88.355-31.56438.162-30.876572.609616.596-57.033
Cash At End Of Period 732.72843.768948.8621,094.6191,172.0611,258.6681,369.5811,345.511,420.8351,535.8451,592.9281,765.295253.302314.267385.877474.232505.796467.634572.609616.5961,492.971